John Smither

John Smither

Directeur Financier/CFO chez MBX BIOSCIENCES, INC.

Fortune : 353 748 $ au 30/06/2026

73 ans
Health Technology
Commercial Services
Consumer Services

Profil

John William Smither is currently Independent Director at Genelux Corp.
since 2023, Independent Non-Executive Director at NewAmsterdam Pharma Co. NV since 2023, Director at eFFECTOR Therapeutics Operations, Inc. since 2018, Independent Director at Attovia Therapeutics, Inc. starting 2026, Chief Financial Officer at MBX Biosciences, Inc. starting 2026, and a Member of The American Institute of Certified Public Accountants, Financial Executives International, and California Society of Certified Public Accountants.
Former positions include Independent Director at Achaogen, Inc. from 2013 to 2020, Independent Director at Principia Biopharma, Inc. in 2019, Director at Dompe Biotec SpA, Independent Director at eFFECTOR Therapeutics, Inc. from 2018 to 2023, Independent Director at Applied Molecular Transport, Inc. from 2022 to 2023, Vice President-Finance & Administration at Amgen, Inc. from 2001 to 2004, Chief Financial Officer at Kythera Biopharmaceuticals LLC from 2007 to 2015, Audit Partner at Ernst & Young LLP (Missouri), Chief Financial Officer at Amgen Europe BV from 2001 to 2004, Chief Financial Officer at Kite Pharma, Inc. from 2017 to 2018, Chief Financial Officer at Unity Biotechnology, Inc. from 2016 to 2017, Chief Financial Officer at Sienna Biopharmaceuticals, Inc. from 2016 to 2017 and again from 2018 to 2019, Chief Financial Officer at Arcutis Biotherapeutics, Inc. from 2019 to 2021 and from 2023 to 2024.
Education includes undergraduate studies at California State University-Los Angeles.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/07/2026 91 403 ( 0,2% ) 275 123 $ 30/06/2026
15/04/2026 2 320 ( 0% ) 78 625 $ 30/06/2026

Postes actifs de John Smither

SociétésPosteDébut
FRAZIER LIFESCIENCES ACQUISITION CORPORATION Directeur/Membre du Conseil 01/01/2023
GENELUX CORPORATION Directeur/Membre du Conseil 11/09/2023
MBX BIOSCIENCES, INC. Directeur Financier/CFO 01/03/2026
Directeur/Membre du Conseil 23/03/2018
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Directeur/Membre du Conseil 01/07/2026

Anciens postes connus de John Smither

SociétésPosteFin
ARCUTIS BIOTHERAPEUTICS, INC. Directeur Financier/CFO 10/04/2024
░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de John Smither

Formation de John Smither

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

58

Relations au 1er degré

22

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées22

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. John Smither